Lantheus Holdings, Inc. (LNTH) intrinsic value & 10-year financials

Lantheus Holdings, Inc. (LNTH) has a Graham intrinsic value of $113.27 per share. At $99.70 on Oct 17, 2026, the stock trades 12% below that value. Over the last 10 fiscal years revenue grew 19.9% a year to $1.5B, with an average return on invested capital of 23.5%.

Graham intrinsic value
$113.27
Share price (Oct 17, 2026)
$99.70
Price vs Graham value
12% below
Market cap
$6.8B
Revenue (FY2025)
$1.5B
Revenue growth (10-yr CAGR)
19.9%
ROIC (10-yr avg)
23.5%
Free cash flow (FY2025)
$390.1M

LNTH 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.5B $233.6M $3.41 $390.1M 20.2% 22.7%
FY2024 $1.5B $312.4M $4.36 $463.8M 29.8% 47.1%
FY2023 $1.3B $326.7M $4.65 $259.9M 28.1% 46.2%
FY2022 $935.1M $28.1M $0.40 $21.8M 3.9% 6.3%
FY2021 $425.2M -$71.3M -$1.06 $41.8M -14.3% -9.4%
FY2020 $339.4M -$13.5M -$0.25 $3.9M -1.2% -0.9%
FY2019 $347.3M $31.7M $0.79 $58.3M 14.9% 23.4%
FY2018 $343.4M $40.5M $1.03 $41.1M 18.8% 24.0%
FY2017 $331.4M $123.4M $3.17 $37.2M 15.6% 30.9%
FY2016 $301.9M $26.8M $0.82 $42.2M 18.7% 44.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Lantheus Holdings, Inc. is a consistent compounder, expanding top-line revenue at 19.9% annually over the past decade.

Lantheus Holdings, Inc. has earned high returns on invested capital, averaging 23.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Lantheus Holdings, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Lantheus Holdings, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $113.27 per share.

LNTH stock: frequently asked questions

What is the intrinsic value of Lantheus Holdings, Inc. (LNTH) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, LNTH's intrinsic value is about $113.27 per share.

Is LNTH stock undervalued?

At $99.70 (close on Oct 17, 2026), LNTH trades 12% below its Graham value of $113.27. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Lantheus Holdings, Inc. grown?

Revenue went from $301.9M in fiscal 2016 to $1.5B in fiscal 2025, a compound annual growth rate of 19.9%. Net income was $233.6M in fiscal 2025.

Does Lantheus Holdings, Inc. generate free cash flow?

Lantheus Holdings, Inc. generated $390.1M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is LNTH's return on invested capital?

Average ROIC over the last 10 fiscal years was 23.5%, and average return on equity was -10.8%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this LNTH data come from?

From Lantheus Holdings, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 7, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar in vitro & in vivo diagnostic substances stocks